Represent

Lobbying
Lobbying by Quest Diagnostics Incorporated

Lobbying Relationship

Client

Quest Diagnostics Incorporated

More records

Lobbying firm

QUEST DIAGNOSTICS INCORPORATED

More records

Federal policy and programs regarding oncology research and development related to cancer screening, diagnosis, and survivorship Federal policy related to strengthening the clinical laboratory workforce H.R. 3248 - Diagnostic Lab Testing Transparency Act H.R. 5378 - Lower Costs, More Transparency Act H.R. 2369 - the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023 Food and Drug Administration (FDA) policies related to diagnostics and laboratory regulation
P.L. 117-328/H.R. 2617- Consolidated Appropriations Act of 2023, provisions related to Medicare reimbursement for clinical diagnostics laboratory services H.R. 2377/S. 1000 - Saving Access to Laboratory Services Act, provisions related to Medicare reimbursement for clinical diagnostics laboratory services P.L. 118-22/H.R. 6363 - Further Continuing Appropriations and Other Extensions Act, 2024 H.R. 4917 - Expanding Seniors Access to PFAS Testing Act Federal policy related to coverage and reimbursement of clinical laboratory services under the Medicare program

Duration: January 1, 2008 to present

General Issues: Health Issues, Medicare/Medicaid, Homeland Security, Medical/Disease Research/Clinical Labs, Defense

Spending: about $16,837,500 (But it's complicated. Here's why.)

Agencies lobbied since 2008: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), Health Resources & Services Administration (HRSA), Administration for Children & Families (ACF), Homeland Security - Dept of (DHS), Office of the Vice President of the United States, President of the U.S., Defense - Dept of (DOD), U.S. Senate,, House of Representatives,, Centers For Medicare and Medicaid Services (CMS)

Bills mentioned

H.R.2914: Build a Better VA Act

Sponsor: Julia Brownley (D-Calif.)

H.R.6: 21st Century Cures Act

Sponsor: Fred Upton (R-Mich.)

H.R.2914: Promoting Integrity in Medicare Act of 2013

Sponsor: Jackie Speier (D-Calif.)

H.R.3207: Modernizing Laboratory Test Standards for Patients Act of 2011

Sponsor: Michael C. Burgess (R-Texas)

H.R.5651: Food and Drug Administration Reform Act of 2012

Sponsor: Fred Upton (R-Mich.)

S.3187: Food and Drug Administration Safety and Innovation Act

Sponsor: Tom Harkin (D-Iowa)

H.R.2194: GEDI Act

Sponsor: Eliot L. Engel (D-N.Y.)

S.1221: GEDI Act

Sponsor: Jeanne Shaheen (D-N.H.)

H.R.3630: Middle Class Tax Relief and Job Creation Act of 2012

Sponsor: Dave Camp (R-Mich.)

H.R.3765: Temporary Payroll Tax Cut Continuation Act of 2011

Sponsor: Dave Camp (R-Mich.)

S.365: Budget Control Act of 2011

Sponsor: Tom Harkin (D-Iowa)

H.R.2847: Hiring Incentives to Restore Employment Act

Sponsor: Alan B. Mollohan (D-W.Va.)

H.R.3590: Patient Protection and Affordable Care Act

Sponsor: Charles B. Rangel (D-N.Y.)

H.R.4213: Unemployment Compensation Extension Act of 2010

Sponsor: Charles B. Rangel (D-N.Y.)

H.R.4872: Health Care and Education Reconciliation Act of 2010

Sponsor: John M. Spratt Jr. (D-S.C.)

H.R.3961: An Act to extend expiring provisions of the USA PATRIOT Improvement and...

Sponsor: John D. Dingell (D-Mich.)

H.R.4691: Temporary Extension Act of 2010

Sponsor: Charles B. Rangel (D-N.Y.)

H.R.4851: Continuing Extension Act of 2010

Sponsor: Sander M. Levin (D-Mich.)

H.R.3200: America's Affordable Health Choices Act of 2009

Sponsor: John D. Dingell (D-Mich.)

H.R.3962: Preservation of Access to Care for Medicare Beneficiaries and Pension...

Sponsor: John D. Dingell (D-Mich.)

S.1796: America's Healthy Future Act of 2009

Sponsor: Max Baucus (D-Mont.)

S.1679: Affordable Health Choices Act

Sponsor: Tom Harkin (D-Iowa)

H.R.3453: Community Clinical Laboratory Fairness in Competition Act of 2007

Sponsor: Nydia M. Velázquez (D-N.Y.)

H.R.6357: PRO(TECH)T Act of 2008

Sponsor: John D. Dingell (D-Mich.)

H.R.2029: To facilitate the restoration of the native ecosystem on Santa Rosa...

Sponsor: Lois Capps (D-Calif.)

H.R.6331: Medicare Improvements for Patients and Providers Act of 2008

Sponsor: Charles B. Rangel (D-N.Y.)

S.2465: Sickle Cell Disease and Other Heritable Blood Disorders Research,...

Sponsor: Tim Scott (R-S.C.)

H.R.6201: Families First Coronavirus Response Act

Sponsor: Nita M. Lowey (D-N.Y.)

H.R.1865: Further Consolidated Appropriations Act, 2020

Sponsor: Bill Pascrell Jr. (D-N.J.)

H.R.748: CARES Act

Sponsor: Joe Courtney (D-Conn.)

H.R.266: Paycheck Protection Program and Health Care Enhancement Act

Sponsor: Betty McCollum (D-Minn.)

H.R.6102: VALID Act of 2020

Sponsor: Diana DeGette (D-Colo.)

S.3404: VALID Act of 2020

Sponsor: Richard M. Burr (R-N.C.)

S.2246: Allergy Testing Access Act of 2019

Sponsor: Jerry Moran (R-Kan.)

H.R.2009: Removing Barriers to Allergy Diagnostic Testing Act of 2019

Sponsor: Yvette D. Clarke (D-N.Y.)

H.R.925: The Heroes Act

Sponsor: Mike Thompson (D-Calif.)

H.R.8496: SPEEDY COVID-19 Tests Act

Sponsor: Mikie Sherrill (D-N.J.)

H.R.8406: The Heroes Act

Sponsor: Nita M. Lowey (D-N.Y.)

H.R.133: Consolidated Appropriations Act, 2021

Sponsor: Henry Cuellar (D-Texas)

H.R.1765: Donald Payne Sr. Colorectal Cancer Detection Act of 2019

Sponsor: Donald M. Payne Jr. (D-N.J.)

H.R.8702: Holding Providers Harmless From Medicare Cuts During COVID–19 Act of 2020

Sponsor: Ami Bera (D-Calif.)

S.5007: Holding Providers Harmless From Medicare Cuts During COVID–19 Act of 2020

Sponsor: John Boozman (R-Ark.)

H.R.748: Ethan's Law

Sponsor: Rosa DeLauro (D-Conn.)

H.R.133: David’s Law

Sponsor: Sheila Jackson Lee (D-Texas)

H.R.1319: American Rescue Plan Act of 2021

Sponsor: John Yarmuth (D-Ky.)

H.R.791: Tracking COVID–19 Variants Act

Sponsor: Ami Bera (D-Calif.)

S.236: Tracking COVID–19 Variants Act

Sponsor: Tammy Baldwin (D-Wis.)

H.R.1865: Jenna Quinn Law

Sponsor: Susan Wild (D-Pa.)

H.R.6201: National Liberty Memorial Preservation Act

Sponsor: Bonnie Watson Coleman (D-N.J.)

H.R.4128: VALID Act of 2021

Sponsor: Diana DeGette (D-Colo.)

S.2209: VALID Act of 2021

Sponsor: Richard M. Burr (R-N.C.)

S.610: Protecting Medicare and American Farmers from Sequester Cuts Act

Sponsor: Tim Kaine (D-Va.)

S.3593: Telehealth Extension and Evaluation Act

Sponsor: Catherine Cortez Masto (D-Nev.)

S.4348: FDASLA Act of 2022

Sponsor: Patty Murray (D-Wash.)

H.R.8152: American Data Privacy and Protection Act

Sponsor: Frank Pallone (D-N.J.)

H.R.8188: Saving Access to Laboratory Services Act

Sponsor: Bill Pascrell Jr. (D-N.J.)

S.4449: Saving Access to Laboratory Services Act

Sponsor: Richard M. Burr (R-N.C.)

H.R.4040: Advancing Telehealth Beyond COVID–19 Act of 2021

Sponsor: Liz Cheney (R-Wyo.)

H.R.2617: Consolidated Appropriations Act, 2023

Sponsor: Gerald E. Connolly (D-Va.)

H.R.748: Stop CCP Infrastructure Act

Sponsor: Claudia Tenney (R-N.Y.)

H.R.1319: Biking on Long-Distance Trails Act

Sponsor: Joe Neguse (D-Colo.)

H.R.2369: VALID Act of 2023

Sponsor: Larry Bucshon (R-Ind.)

H.R.1770: Equitable Community Access to Pharmacist Services Act

Sponsor: Adrian Smith (R-Neb.)

H.R.2617: Choices for Stranded Passengers Act of 2023

Sponsor: Katie Porter (D-Calif.)

H.R.2377: Saving Access to Laboratory Services Act

Sponsor: Richard Hudson (R-N.C.)

S.1000: Saving Access to Laboratory Services Act

Sponsor: Sherrod Brown (D-Ohio)

H.R.4363: Comprehensive Cancer Survivorship Act

Sponsor: Debbie Wasserman Schultz (D-Fla.)

H.R.3248: Diagnostic Lab Testing Transparency Act

Sponsor: Mariannette Miller-Meeks (R-Iowa)

H.R.4421: Preparing for All Hazards and Pathogens Reauthorization Act

Sponsor: Richard Hudson (R-N.C.)

H.R.4420: Preparedness and Response Reauthorization Act

Sponsor: Richard Hudson (R-N.C.)

H.R.5378: Lower Costs, More Transparency Act

Sponsor: Cathy McMorris Rodgers (R-Wash.)

H.R.6363: Further Continuing Appropriations and Other Extensions Act, 2024

Sponsor: Kay Granger (R-Texas)

H.R.4917: Expanding Seniors’ Access to PFAS Testing Act

Sponsor: Dan Kildee (D-Mich.)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist	Covered positions?
Emma Lange	Special Assistant-Department of Energy
Dolly Judge	n/a
Faith Cristol	n/a
Faith Cristol A	n/a
KRISTEN CUSICK	n/a
Terese Colling	n/a
BOB HYNES	n/a
AL SWIFT	n/a
CAROLYN KIM MCCARTHY	n/a
Cristol Faith A	n/a
Judge Dolly A	n/a
Silverman Charles J	n/a
Gonzalez Ariel A	n/a
Charles Silverman	n/a
Ariel Gonzalez	n/a
Ashli Douglas	n/a
Sherry Widicus	n/a
Ishan Shah	n/a

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

0th Quarter, 2005

Registration

1st Quarter, 2024

Q1 Report

In Q1, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on April 22. Original Filing: 301571049.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2023

Q4 Report

In Q4, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on Jan. 22. Original Filing: 301536292.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2023

Q3 Report

In Q3, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on Oct. 20, 2023. Original Filing: 301513592.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2023

Amendment

QUEST DIAGNOSTICS INCORPORATED amended a lobbying report for in-house lobbying in Q22023 on Oct. 20, 2023 Original Filing: 301513606.xml

Lobbying Issues

Monitor implementation of H.R. 6201, the Families First Coronavirus Response Act (Public Law 116-127), and provisions related to clinical laboratory testing for COVID-19, including coverage and reimbursement of COVID-19 tests Monitor implementation of H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act, the CARES Act, (Public Law 116-136), and provisions related to clinical laboratory testing for COVID-19, including coverage and reimbursement of COVID-19 tests, laboratory data collection and reimbursement under PAMA, and laboratory data reporting H.R.1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2) and provisions related to clinical laboratory testing for COVID-19 H.R. 2369 - the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023 Federal policy and programs ensuring an equitable pandemic response and recovery, including coverage of COVID-19 testing services for uninsured patients Federal policy and programs regarding oncology research and development related to cancer screening, diagnosis, and survivorship H.R. 4363 - The Comprehensive Cancer Survivorship Act Federal policy related to strengthening the clinical laboratory workforce Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) H.R. 1770 - Equitable Community Access to Pharmacist Services Act H.R. 3248 - Diagnostic Lab Testing Transparency Act

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2023

Q2 Report

In Q2, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on July 20, 2023. Original Filing: 301488070.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2023

Q1 Report

In Q1, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on April 20, 2023. Original Filing: 301462888.xml

Lobbying Issues

Monitor implementation of H.R. 6201, the Families First Coronavirus Response Act (Public Law 116-127), and provisions related to clinical laboratory testing for COVID-19, including coverage and reimbursement of COVID-19 tests Monitor implementation of H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act, the CARES Act, (Public Law 116-136), and provisions related to clinical laboratory testing for COVID-19, including coverage and reimbursement of COVID-19 tests, laboratory data collection and reimbursement under PAMA, and laboratory data reporting H.R.1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2) and provisions related to clinical laboratory testing for COVID-19 H.R. 2369 - the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023 Federal policy and programs ensuring an equitable pandemic response and recovery, including coverage of COVID-19 testing services for uninsured patients Federal policy and programs regarding oncology research and development related to cancer screening, diagnosis, and survivorship Federal policy related to strengthening the clinical laboratory workforce Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) H.R. 1770 - Equitable Community Access to Pharmacist Services Act

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2022

Q4 Report

In Q4, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on Jan. 20, 2023. Original Filing: 301437575.xml

Lobbying Issues

Monitor implementation of H.R. 6201, the Families First Coronavirus Response Act (Public Law 116-127), and provisions related to clinical laboratory testing for COVID-19, including coverage and reimbursement of COVID-19 tests Monitor implementation of H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act, the CARES Act, (Public Law 116-136), and provisions related to clinical laboratory testing for COVID-19, including coverage and reimbursement of COVID-19 tests, laboratory data collection and reimbursement under PAMA, and laboratory data reporting H.R.1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2) and provisions related to clinical laboratory testing for COVID-19 H.R. 4128/S. 2209 - the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 S. 4348, the Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act and the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2022 Federal policy and programs ensuring an equitable pandemic response and recovery, including coverage of COVID-19 testing services for uninsured patients H.R. 8152 - American Data Privacy and Protection Act, provisions related to health data privacy Issues related to validation, deployment, and reimbursement for testing to address 2022 Monkeypox outbreak Federal policy and programs regarding oncology research and development related to cancer screening, diagnosis, and survivorship

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2022

Q3 Report

In Q3, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on Oct. 20, 2022. Original Filing: 301416553.xml

Lobbying Issues

Monitor implementation of H.R. 6201, the Families First Coronavirus Response Act (Public Law 116-127), and provisions related to clinical laboratory testing for COVID-19, including coverage and reimbursement of COVID-19 tests Monitor implementation of H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act, the CARES Act, (Public Law 116-136), and provisions related to clinical laboratory testing for COVID-19, including coverage and reimbursement of COVID-19 tests, laboratory data collection and reimbursement under PAMA, and laboratory data reporting H.R.1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2) and provisions related to clinical laboratory testing for COVID-19 H.R. 4128/S. 2209 - the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 S. 4348, the Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act and the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2022 Federal policy and programs ensuring an equitable pandemic response and recovery, including coverage of COVID-19 testing services for uninsured patients H.R. 8152 - American Data Privacy and Protection Act, provisions related to health data privacy Issues related to validation, deployment, and reimbursement for testing to address 2022 Monkeypox outbreak Federal policy and programs regarding oncology research and development related to cancer screening, diagnosis, and survivorship

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2022

Q2 Report

In Q2, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on July 20, 2022. Original Filing: 301392290.xml

Lobbying Issues

Monitor implementation of H.R. 6201, the Families First Coronavirus Response Act (Public Law 116-127), and provisions related to clinical laboratory testing for COVID-19, including coverage and reimbursement of COVID-19 tests Monitor implementation of H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act, the CARES Act, (Public Law 116-136), and provisions related to clinical laboratory testing for COVID-19, including coverage and reimbursement of COVID-19 tests, laboratory data collection and reimbursement under PAMA, and laboratory data reporting H.R.1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2) and provisions related to clinical laboratory testing for COVID-19 H.R. 4128/S. 2209, the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 S. 4348, the Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act and the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2022 Federal policy and programs ensuring an equitable pandemic response and recovery, including coverage of COVID-19 testing services for uninsured patients H.R. 8152 - American Data Privacy and Protection Act (ADPPA), provisions related to health data privacy Issues related to validation, deployment, and reimbursement for testing to address 2022 Monkeypox outbreak

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2022

Q1 Report

In Q1, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on April 19, 2022. Original Filing: 301364117.xml

Lobbying Issues

Monitor implementation of H.R. 6201, the Families First Coronavirus Response Act (Public Law 116-127), and provisions related to clinical laboratory testing for COVID-19, including coverage and reimbursement of COVID-19 tests. Monitor implementation of H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act, the CARES Act, (Public Law 116-136), and provisions related to clinical laboratory testing for COVID-19, including coverage and reimbursement of COVID-19 tests, laboratory data collection and reimbursement under PAMA, and laboratory data reporting. Monitor implementation of H.R.1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2) and provisions related to clinical laboratory testing for COVID-19; Section 2402, support for SARS-COV-2 genomic sequencing and surveillance. H.R. 4128/S. 2209, the Verifying Accurate Leading-edge IVCT Development (VALID) Act, provisions relating to FDA oversight of laboratory-developed tests. Issues related to clinical laboratories and implementation of surprise billing and price transparency law (PL 116-260). Federal policy and programs ensuring an equitable pandemic response and recovery. S.3593 - Telehealth Extension and Evaluation Act. FY 2023, Labor, Health and Human Services, Education and Related Agencies bill and issues related to harmonizing the reporting of clinical laboratory test results and pediatric reference intervals.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2021

Q4 Report

In Q4, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on Jan. 20, 2022. Original Filing: 301337943.xml

Lobbying Issues

Monitor implementation of H.R. 6201, the Families First Coronavirus Response Act (Public Law 116-127), and provisions related to clinical laboratory testing for COVID-19, including coverage and reimbursement of COVID-19 tests. Monitor implementation of H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act, the CARES Act, (Public Law 116-136), and provisions related to clinical laboratory testing for COVID-19, including coverage and reimbursement of COVID-19 tests, laboratory data collection and reimbursement under PAMA, and laboratory data reporting. H.R. 1319 - American Rescue Plan Act of 2021 (Public Law 117-2) and provisions related to clinical laboratory testing for COVID-19; Section 2402, support for SARS-COV-2 genomic sequencing and surveillance. H.R. 4128/S. 2209, the Verifying Accurate Leading-edge IVCT Development (VALID) Act, provisions relating to FDA oversight of laboratory-developed tests. Issues related to clinical laboratories and implementation of surprise billing and price transparency law (Public Law 116-260). Federal policy and programs ensuring an equitable pandemic response and recovery. FY2022 Labor, Health and Human Services, Education and Related Agencies bill and the Advanced Molecular Detection (AMD) program at the CDC.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2021

Registration

3rd Quarter, 2021

Q3 Report

In Q3, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on Oct. 20, 2021. Original Filing: 301312392.xml

Lobbying Issues

Monitor implementation of H.R. 6201, the Families First Coronavirus Response Act (Public Law 116-127), and provisions related to clinical laboratory testing for COVID-19, including coverage and reimbursement of COVID-19 diagnostic tests. Monitor implementation of H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act, the CARES Act, (Public Law 116-136), and provisions related to clinical laboratory testing for COVID-19, including coverage and reimbursement of COVID-19 diagnostic tests, laboratory data collection and reimbursement under PAMA, and laboratory data reporting. Laboratory Developed Test (LDT) reform pathway engagement. H.R. 133, Consolidated Appropriations Act, 2021 (Public Law 116-260), and provisions related to clinical laboratory testing for COVID-19. H.R.1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2) and provisions related to clinical laboratory testing for COVID-19; Section 2402, support for SARS-COV-2 genomic sequencing and surveillance. Tracking COVID-19 Variants Act (H.R. 791, S. 236), legislation to support genomic surveillance and expand sequencing of SARS-CoV-2. Issues related to the implementation of surprise billing law related to laboratory treatments. Federal policy and programs related to K-12 schools testing for COVID-19. Federal policy and programs ensuring an equitable pandemic response and recovery.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2021

Q2 Report

In Q2, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on July 20, 2021. Original Filing: 301289815.xml

Lobbying Issues

Monitor implementation of H.R. 6201, the Families First Coronavirus Response Act (Public Law 116-127), and provisions related to clinical laboratory testing for COVID-19, including coverage and reimbursement of COVID-19 diagnostic tests. Monitor implementation of H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act, the CARES Act, (Public Law 116-136), and provisions related to clinical laboratory testing for COVID-19, including coverage and reimbursement of COVID-19 diagnostic tests, laboratory data collection and reimbursement under PAMA, and laboratory data reporting. Laboratory Developed Test (LDT) reform pathway engagement. H.R. 133, Consolidated Appropriations Act, 2021 (Public Law 116-260), and provisions related to clinical laboratory testing for COVID-19. H.R.1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2) and provisions related to clinical laboratory testing for COVID-19; Section 2402, support for SARS-COV-2 genomic sequencing and surveillance. Tracking COVID-19 Variants Act (H.R. 791, S. 236), legislation to support genomic surveillance and expand sequencing of SARS-CoV-2. Issues related to the implementation of surprise billing law related to laboratory treatments. Federal policy and programs related to K-12 schools testing for COVID-19. Federal policy and programs ensuring an equitable pandemic response and recovery.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2021

Q1 Report

In Q1, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on April 20, 2021. Original Filing: 301260796.xml

Lobbying Issues

Monitor implementation of H.R. 6201, the Families First Coronavirus Response Act (Public Law 116-127), and provisions related to clinical laboratory testing for COVID-19, including coverage and reimbursement of COVID-19 diagnostic tests. Monitor implementation of H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act, the CARES Act, (Public Law 116-136), and provisions related to clinical laboratory testing for COVID-19, including coverage and reimbursement of COVID-19 diagnostic tests, laboratory data collection and reimbursement under PAMA, and laboratory data reporting. Laboratory Developed Test (LDT) reform pathway engagement. H.R. 133, Consolidated Appropriations Act, 2021 (Public Law 116-260), and provisions related to clinical laboratory testing for COVID-19. H.R.1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2) and provisions related to clinical laboratory testing for COVID-19; Section 2402, support for SARS-COV-2 genomic sequencing and surveillance. Tracking COVID-19 Variants Act (H.R. 791, S. 236), legislation to support genomic surveillance and expand sequencing of SARS-CoV-2. Issues related to the implementation of surprise billing law related to laboratory treatments. Issues related to the promulgation of the previous Administrations actions regarding price transparency for health care providers. Federal policy and programs related to K-12 schools testing for COVID-19. Federal policy and programs ensuring an equitable pandemic response and recovery.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2020

Q4 Report

In Q4, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on Jan. 20, 2021. Original Filing: 301242259.xml

Lobbying Issues

Monitor implementation of H.R. 6201, the Families First Coronavirus Response Act (Public Law 116-127), and provisions related to clinical laboratory testing for COVID-19, including coverage and reimbursement of COVID-19 diagnostic tests Monitor implementation of H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act, the CARES Act, (Public Law 116-136), and provisions related to clinical laboratory testing for COVID-19, including coverage and reimbursement of COVID-19 diagnostic tests, laboratory data collection and reimbursement under PAMA, and laboratory data reporting Federal policy relating to implementation of anti-kickback requirements in Section 8122 of the Support for Patients and Communities Act, Public Law 115-271 H.R. 6102/S. 3404, the Verifying Accurate Leading-edge IVCT Development (VALID) Act, provisions relating to FDA oversight of laboratory-developed tests The Public Readiness and Emergency Preparedness Act (PREP Act) and COVID-19 liability protection for frontline health care providers, including CLIA-licensed laboratories and their personnel H.R. 8496, the SPEEDY COVID-19 Tests Act, relating to varying Medicare reimbursement for COVID-19 tests based on result delivery time Section 307 of H.R. 8406, the Heroes Act, provisions relating to coverage of COVID-19 testing H.R. 133, Consolidated Appropriations Act, 2021 (Public Law 116-260), and provisions related to clinical laboratory testing for COVID-19, and Medicare reimbursement for pathology services

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2020

Q3 Report

In Q3, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on Oct. 20, 2020. Original Filing: 301219637.xml

Lobbying Issues

Monitor implementation of H.R. 6201, the Families First Coronavirus Response Act (Public Law 116-127), and provisions related to clinical laboratory testing for COVID-19, including coverage and reimbursement of COVID-19 diagnostic tests. Monitor implementation of H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act, the CARES Act, (Public Law 116-136), and provisions related to clinical laboratory testing for COVID-19, including coverage and reimbursement of COVID-19 diagnostic tests, laboratory data collection and reimbursement under PAMA, and laboratory data reporting. Federal policy relating to implementation of anti-kickback requirements in Section 8122 of the Support for Patients and Communities Act, Public Law 115-271. H.R. 6102/S. 3404, the Verifying Accurate Leading-edge IVCT Development (VALID) Act, provisions relating to FDA oversight of laboratory-developed tests. The Public Readiness and Emergency Preparedness Act (PREP Act) and COVID-19 liability protection for frontline health care providers, including CLIA-licensed laboratories and their personnel. H.R.925 - the Heroes Act, and provisions related to coverage for COVID-19 testing

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2020

Q2 Report

In Q2, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on July 20, 2020. Original Filing: 301200469.xml

Lobbying Issues

H.R. 6201, the Families First Coronavirus Response Act (Public Law 116-127), and provisions related to clinical laboratory testing for COVID-19, including coverage and reimbursement of COVID-19 diagnostic tests. H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act, the CARES Act, (Public Law 116-136), and provisions related to clinical laboratory testing for COVID-19, including coverage and reimbursement of COVID-19 diagnostic tests, laboratory data collection and reimbursement under PAMA, and laboratory data reporting. H.R.266, Paycheck Protection Program and Health Care Enhancement Act (Public Law 116-139), and provisions related to COVID-19 testing capacity. FY2021 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations as it relates to regulation and oversight of clinical laboratories, including laboratory-developed test services and pharmacogenetic testing. FY2021 CDC appropriations for improved pediatric reference intervals and harmonizing the reporting of clinical laboratory test results. Federal policy relating to implementation of anti-kickback requirements in Section 8122 of the Support for Patients and Communities Act, Public Law 115-271. H.R. 6102/S. 3404, the Verifying Accurate Leading-edge IVCT Development (VALID) Act, provisions relating to FDA oversight of laboratory-developed tests. The Public Readiness and Emergency Preparedness Act (PREP Act) and COVID-19 liability protection for frontline health care providers, including CLIA-licensed laboratories and their personnel.

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2020

Q1 Report

In Q1, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on April 20, 2020. Original Filing: 301179442.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2019

Q4 Report

3rd Quarter, 2019

Q3 Report

2nd Quarter, 2019

Q2 Report

In Q2, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on July 19, 2019. Original Filing: 301052743.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2019

Q1 Report

In Q1, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on April 22, 2019. Original Filing: 301038624.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2018

Q4 Report

In Q4, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on Jan. 21, 2019. Original Filing: 301012300.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2018

Q3 Report

In Q3, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on Oct. 20, 2018. Original Filing: 300993511.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2018

Q2 Report

In Q2, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on July 20, 2018. Original Filing: 300977548.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2018

Q1 Report

4th Quarter, 2017

Q4 Report

3rd Quarter, 2017

Q3 Report

2nd Quarter, 2017

Q2 Report

In Q2, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on July 20, 2017. Original Filing: 300896151.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2017

Q1 Report

In Q1, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on April 20, 2017. Original Filing: 300873950.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2016

Q4 Report

In Q4, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on Jan. 20, 2017. Original Filing: 300852386.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2016

Q3 Report

In Q3, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on Oct. 20, 2016. Original Filing: 300839058.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2016

Q2 Report

In Q2, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on July 19, 2016. Original Filing: 300814785.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2016

Q1 Report

In Q1, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on April 20, 2016. Original Filing: 300801280.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2015

Q4 Report

In Q4, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on Jan. 20, 2016. Original Filing: 300780197.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2015

Q3 Report

In Q3, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on Oct. 20, 2015. Original Filing: 300764304.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2015

Q2 Report

In Q2, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on July 20, 2015. Original Filing: 300745589.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2015

Q1 Report

In Q1, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on April 20, 2015. Original Filing: 300722439.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2014

Q4 Report

In Q4, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on Jan. 19, 2015. Original Filing: 300700344.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2014

Q3 Report

In Q3, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on Oct. 20, 2014. Original Filing: 300687516.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2014

Q2 Report

In Q2, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on July 21, 2014. Original Filing: 300668326.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2014

Q1 Report

In Q1, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on April 18, 2014. Original Filing: 300642234.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2013

Q4 Report

In Q4, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on Jan. 21, 2014. Original Filing: 300623324.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2013

Q3 Report

In Q3, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on Oct. 21, 2013. Original Filing: 300602629.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2013

Registration

2nd Quarter, 2013

Q2 Report

In Q2, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on July 19, 2013. Original Filing: 300577998.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2013

Q1 Report

In Q1, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on April 19, 2013. Original Filing: 300556323.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2012

Q4 Report

In Q4, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on Jan. 21, 2013. Original Filing: 300536973.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2012

Q3 Report

In Q3, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on Oct. 19, 2012. Original Filing: 300512298.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2012

Q2 Report

In Q2, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on July 19, 2012. Original Filing: 300491361.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2012

Q1 Report

In Q1, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on April 18, 2012. Original Filing: 300464434.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2012

Registration

4th Quarter, 2011

Q4 Report

In Q4, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on Jan. 19, 2012. Original Filing: 300444388.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2011

Q3 Report

In Q3, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on Oct. 19, 2011. Original Filing: 300419796.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2011

Amendment

QUEST DIAGNOSTICS INCORPORATED amended a lobbying report for in-house lobbying in Q22011 on Oct. 19, 2011 Original Filing: 300418776.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2011

Q2 Report

In Q2, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on July 19, 2011. Original Filing: 300397472.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2011

Amendment

QUEST DIAGNOSTICS INCORPORATED amended a lobbying report for in-house lobbying in Q12011 on July 18, 2011 Original Filing: 300392235.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2011

Q1 Report

In Q1, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on April 20, 2011. Original Filing: 300379396.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

4th Quarter, 2010

Q4 Report

In Q4, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on Jan. 18, 2011. Original Filing: 300340724.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2010

Q3 Report

In Q3, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on Oct. 20, 2010. Original Filing: 300324843.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2010

Q2 Report

In Q2, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on July 18, 2010. Original Filing: 300290778.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2010

Q1 Report

In Q1, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on April 17, 2010. Original Filing: 300261738.xml

Lobbying Issues

Health care reform including clinical laboratory payment issues; technical component grandfather extension (H.R. 2847, Hiring Incentives to Restore Employment Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4213, American Workers, State, and Business Relief Act of 2010; H.R. 4872, Health Care and Education Reconciliation Act of 2010); continued on next page.Continued: sustainable growth rate extension (H.R. 3961, Medicare Physician Payment Reform Act of 2009; H.R. 4691, Temporary Extension Act of 2010; H.R. 4851, Continuing Extension Act); laboratory issues (no specific bills) include results to patients, self-referral abuses relating to anatomic pathology, statutory authority of laboratory services, genetic information and testing.

Agencies Lobbied

Type of Issue

4th Quarter, 2009

Q4 Report

In Q4, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on Jan. 19, 2010. Original Filing: 300239859.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2009

Q3 Report

In Q3, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on Oct. 16, 2009. Original Filing: 300206905.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

3rd Quarter, 2009

Q3 Report

In Q3, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on Oct. 15, 2009. Original Filing: 300206020.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

2nd Quarter, 2009

Q2 Report

1st Quarter, 2009

Q1 Report

4th Quarter, 2008

Q4 Report

3rd Quarter, 2008

Q3 Report

2nd Quarter, 2008

Q2 Report

In Q2, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on July 17, 2008. Original Filing: 300070341.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2008

Amendment

QUEST DIAGNOSTICS INCORPORATED amended a lobbying report for in-house lobbying in Q12008 on July 17, 2008 Original Filing: 300070239.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Lobbying Issues

Agencies Lobbied

Type of Issue

1st Quarter, 2008

Q1 Report

In Q1, QUEST DIAGNOSTICS INCORPORATED had in-house lobbyists. The report was filed on April 21, 2008. Original Filing: 300054309.xml

Lobbying Issues

Agencies Lobbied

Type of Issue

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Legislators

Bills

Statements

Lobbying

Travel

Lobbyists

Disclosures Filed